Skip to content
Screener

ADMA Biologics ADMA ADMA Bio Manufacturing — Cost Of Revenue

Other segment segments

Plasma Collection Centers
$554K—

Similar metrics at other companies

The Greenbrier Companies logo
GBXManufacturing — Cost Of Revenue
$487M-29.0%
FreightCar America logo
RAILManufacturing — Cost Of Revenue
$45.64M-41.5%
MarineMax logo
HZOProduct Manufacturing — Cost Of Revenue
$29.56M-4.4%
Consolidated Water Company logo
CWCOManufacturing Units — Cost Of Revenue
$1.69M-46.9%
Amplitech Group, Inc. logo
AMPGManufacturing And Engineering — Cost Of Revenue
$1.69M+120%
RFL
RFLCost Of Product Revenue — Cost Of Revenue
$8K-11.1%

Other financials

Income statement

See full
Revenue$124.4M+2.0%
Gross profit$86.3M+28.3%
Operating income$52.4M+22.5%
Net income$37.8M+10.5%
EPS (diluted)$0.16+14.3%

Balance sheet

See full
Cash & equivalents$136.0M+50.7%
Total debt$203.9M+1,855%
Total equity$408.2M+2.5%
Total assets$684.2M+22.5%

Cash flow

See full
Operating cash flow$29.5M+39.7%
CapEx$2.3M-6.9%
Free cash flow$27.3M+45.8%

Valuation

See full
Market cap$2.25B-49.1%
Enterprise value$2.32B-46.6%
P/E13.3×-7.9×
P/S4.4×-4.9×

Profitability

See full
Gross margin64.7%+11.7pp
Operating margin43.8%+11.0pp
Net margin33%-11.1pp
FCF margin22.7%+8.9pp

Returns & leverage

See full
Return on equity41.9%-29.3pp
Debt / equity0.5×+0.5×
Current ratio7×+1.6×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:CostOfRevenue.

The source filing: ADMA Biologics’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:16 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001140361-26-031445
(in thousands)ADMA Bio ManufacturingPlasma Collection CentersTotal
Revenues$$123,637$723124,360
Cost of product revenue37,56455438,118
Research and development6,014-6,014
Plasma center operating expenses-1,0261,026
Gain on sale of plasma centers---
Selling, marketing and distribution7,634-7,634
Depreciation and amortization expense1,2814991,780
General and administrative expense8,340-8,340

Item 1. Financial Statements.

FAQ

What is ADMA Biologics's ADMA bio manufacturing — cost of revenue?
ADMA Biologics (ADMA) reported ADMA bio manufacturing — cost of revenue of $37.56M in Q2 2026.
How has ADMA Biologics's ADMA bio manufacturing — cost of revenue changed year-over-year?
ADMA Biologics's ADMA bio manufacturing — cost of revenue decreased by 31.4% year-over-year, from $54.76M to $37.56M.
What is the long-term trend for ADMA Biologics's ADMA bio manufacturing — cost of revenue?
Over 3 years (2022 to 2025), ADMA Biologics's ADMA bio manufacturing — cost of revenue has grown at a 22.4% compound annual growth rate (CAGR), from $108.88M to $199.86M.
What does ADMA bio manufacturing — cost of revenue mean?
Includes the direct costs attributable to the production of plasma-derived biologics, such as raw materials, direct labor, and manufacturing overhead. Monitoring this metric is essential for assessing the production efficiency and gross margin stability of the manufacturing segment.

Ask your AI about ADMA Biologics's adma bio manufacturing — cost of revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude